Analyst downgrades typically lead to a negative short-term reaction in the stock price as they reflect a less optimistic view on the company's future performance. The significant reduction in the price target from $22 to $13.2 by a major financial institution like UBS is likely to be taken seriously by the market, potentially leading to a decrease in investor confidence and a drop in the stock price.